> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Debars Hampton-Bey Over Misbranded Drugs
- URL: https://www.fdaweb.com/fda-debars-hampton-bey-over-misbranded-drugs/
- Published: 2022-07-14T12:00:00.000Z
- Updated: 2026-09-14T17:51:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152273

*Federal Register* notice: FDA is issuing an order debarring **Kris A. Hampton-Bey II** for a period of five years from importing or offering for import any drug into the U.S. FDA says it based the debarment on a finding that he engaged in a pattern of importing or offering for import misbranded drugs. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-07-13/pdf/2022-14899.pdf?ref=fdaweb.com).